In the last three months, 14 analysts have published ratings on Equifax EFX, offering a diverse range of perspectives from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 7 | 2 | 5 | 0 | 0 |
Last 30D | 1 | 0 | 0 | 0 | 0 |
1M Ago | 2 | 2 | 1 | 0 | 0 |
2M Ago | 2 | 0 | 2 | 0 | 0 |
3M Ago | 2 | 0 | 2 | 0 | 0 |
Analysts have set 12-month price targets for Equifax, revealing an average target of $245.79, a high estimate of $315.00, and a low estimate of $195.00. This upward trend is apparent, with the current average reflecting a 19.32% increase from the previous average price target of $206.00.
Understanding Analyst Ratings: A Comprehensive Breakdown
An in-depth analysis of recent analyst actions unveils how financial experts perceive Equifax. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Heather Balsky | B of A Securities | Raises | Buy | $300.00 | $164.00 |
Kyle Peterson | Needham | Raises | Buy | $305.00 | $230.00 |
George Tong | Goldman Sachs | Raises | Neutral | $222.00 | $195.00 |
Owen Lau | Oppenheimer | Announces | Outperform | $273.00 | - |
Surinder Thind | Jefferies | Raises | Buy | $315.00 | $200.00 |
Seth Weber | Wells Fargo | Raises | Overweight | $290.00 | $200.00 |
Faiza Alwy | Deutsche Bank | Raises | Buy | $267.00 | $218.00 |
Andre Benjamin | Goldman Sachs | Raises | Neutral | $195.00 | $173.00 |
Andre Benjamin | Goldman Sachs | Raises | Neutral | $195.00 | $173.00 |
Arthur Truslove | Citigroup | Announces | Buy | $243.00 | - |
Andrew Jeffrey | Truist Securities | Lowers | Buy | $210.00 | $250.00 |
Seth Weber | Wells Fargo | Lowers | Equal-Weight | $200.00 | $215.00 |
Toni Kaplan | Morgan Stanley | Lowers | Equal-Weight | $196.00 | $204.00 |
Kyle Peterson | Needham | Lowers | Buy | $230.00 | $250.00 |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Equifax. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Equifax compared to the broader market.
- Price Targets: Delving into movements, analysts provide estimates for the future value of Equifax's stock. This analysis reveals shifts in analysts' expectations over time.
Capture valuable insights into Equifax's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
Stay up to date on Equifax analyst ratings.
Delving into Equifax's Background
Along with Experian and TransUnion, Equifax is one of the leading credit bureaus in the United States. Equifax's credit reports provide credit histories on millions of consumers, and the firm's services are critical to lenders' credit decisions. In addition, about a third of the firm's revenue comes from workforce solutions, which provides income verification and employer human resources services. Equifax generates over 20% of its revenue from outside the United States.
Equifax's Financial Performance
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Revenue Growth: Over the 3 months period, Equifax showcased positive performance, achieving a revenue growth rate of 6.01% as of 30 September, 2023. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: Equifax's net margin is impressive, surpassing industry averages. With a net margin of 12.3%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Equifax's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 3.82%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Equifax's ROA stands out, surpassing industry averages. With an impressive ROA of 1.36%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Equifax's debt-to-equity ratio surpasses industry norms, standing at 1.4. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
Analyst Ratings: What Are They?
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.